These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

8027 related articles for article (PubMed ID: 14584018)

  • 41. A randomized placebo controlled trial of vitamin B
    Kwok T; Lee J; Ma RC; Wong SY; Kung K; Lam A; Ho CS; Lee V; Harrison J; Lam L
    Clin Nutr; 2017 Dec; 36(6):1509-1515. PubMed ID: 27823800
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial.
    de Jager CA; Oulhaj A; Jacoby R; Refsum H; Smith AD
    Int J Geriatr Psychiatry; 2012 Jun; 27(6):592-600. PubMed ID: 21780182
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vitamin B12 and cognitive function: an evidence-based analysis.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2013; 13(23):1-45. PubMed ID: 24379897
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of supplementation with vitamins B
    Olaso-Gonzalez G; Inzitari M; Bellelli G; Morandi A; Barcons N; Viña J
    IUBMB Life; 2022 Jan; 74(1):74-84. PubMed ID: 34058062
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vitamin E for Alzheimer's dementia and mild cognitive impairment.
    Farina N; Llewellyn D; Isaac MGEKN; Tabet N
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD002854. PubMed ID: 28418065
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of Folic Acid and Vitamin B12 Supplementation on Cognitive Impairment and Inflammation in Patients with Alzheimer's Disease: A Randomized, Single-Blinded, Placebo-Controlled Trial.
    Chen H; Liu S; Ge B; Zhou D; Li M; Li W; Ma F; Liu Z; Ji Y; Huang G
    J Prev Alzheimers Dis; 2021; 8(3):249-256. PubMed ID: 34101780
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Homocysteine-lowering interventions for preventing cardiovascular events.
    Martí-Carvajal AJ; Solà I; Lathyris D; Dayer M
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD006612. PubMed ID: 28816346
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metrifonate for Alzheimer's disease.
    López-Arrieta JM; Schneider L
    Cochrane Database Syst Rev; 2006 Apr; (2):CD003155. PubMed ID: 16625573
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pre-conception Folic Acid and Multivitamin Supplementation for the Primary and Secondary Prevention of Neural Tube Defects and Other Folic Acid-Sensitive Congenital Anomalies.
    Wilson RD; ; Wilson RD; Audibert F; Brock JA; Carroll J; Cartier L; Gagnon A; Johnson JA; Langlois S; Murphy-Kaulbeck L; Okun N; Pastuck M; ; Deb-Rinker P; Dodds L; Leon JA; Lowel HL; Luo W; MacFarlane A; McMillan R; Moore A; Mundle W; O'Connor D; Ray J; Van den Hof M
    J Obstet Gynaecol Can; 2015 Jun; 37(6):534-52. PubMed ID: 26334606
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects and safety of periconceptional oral folate supplementation for preventing birth defects.
    De-Regil LM; Peña-Rosas JP; Fernández-Gaxiola AC; Rayco-Solon P
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD007950. PubMed ID: 26662928
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Folate and vitamin B12: function and importance in cognitive development.
    Troen AM
    Nestle Nutr Inst Workshop Ser; 2012; 70():161-71. PubMed ID: 25825305
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vitamin supplementation for preventing miscarriage.
    Balogun OO; da Silva Lopes K; Ota E; Takemoto Y; Rumbold A; Takegata M; Mori R
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD004073. PubMed ID: 27150280
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vitamin B6, B12, and folic acid supplementation and cognitive function: a systematic review of randomized trials.
    Balk EM; Raman G; Tatsioni A; Chung M; Lau J; Rosenberg IH
    Arch Intern Med; 2007 Jan; 167(1):21-30. PubMed ID: 17210874
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Donepezil for mild and moderate Alzheimer's disease.
    Birks J S; Melzer D
    Cochrane Database Syst Rev; 2000; (2):CD001190. PubMed ID: 10796620
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of homocysteine lowering treatment on cognitive function: a systematic review and meta-analysis of randomized controlled trials.
    Ford AH; Almeida OP
    J Alzheimers Dis; 2012; 29(1):133-49. PubMed ID: 22232016
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Galantamine for Alzheimer's disease.
    Olin J; Schneider L
    Cochrane Database Syst Rev; 2001; (1):CD001747. PubMed ID: 11279727
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cholinesterase inhibitors for rarer dementias associated with neurological conditions.
    Li Y; Hai S; Zhou Y; Dong BR
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD009444. PubMed ID: 25734590
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effects of blood pressure lowering on development of cognitive impairment and dementia in patients without apparent prior cerebrovascular disease.
    McGuinness B; Todd S; Passmore P; Bullock R
    Cochrane Database Syst Rev; 2006 Apr; (2):CD004034. PubMed ID: 16625595
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rivastigmine for Alzheimer's disease.
    Birks J; Grimley Evans J; Iakovidou V; Tsolaki M; Holt FE
    Cochrane Database Syst Rev; 2009 Apr; (2):CD001191. PubMed ID: 19370562
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vitamin E for Alzheimer's dementia and mild cognitive impairment.
    Farina N; Llewellyn D; Isaac MG; Tabet N
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD002854. PubMed ID: 28128435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 402.